C12N 9/80
Acting on amide bonds in linear amides
Official title: acting on amide bonds in linear amides {(3.5.1)}
C12N9/80 (Acting on amide bonds in linear amides) appears on 784 US grants and 961 published applications in this corpus.
Search patents in C12N- Granted patents
- 784
- Published applications
- 961
- Assignees
- 561
- Inventors
- 2,359
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 7 | 0 |
| 1985 | 4 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 6 | 0 |
| 1990 | 5 | 0 |
| 1991 | 9 | 0 |
| 1992 | 9 | 0 |
| 1993 | 17 | 0 |
| 1994 | 13 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 12 | 0 |
| 1998 | 31 | 0 |
| 1999 | 32 | 0 |
| 2000 | 28 | 0 |
| 2001 | 34 | 2 |
| 2002 | 24 | 34 |
| 2003 | 22 | 50 |
| 2004 | 20 | 39 |
| 2005 | 19 | 29 |
| 2006 | 14 | 27 |
| 2007 | 19 | 21 |
| 2008 | 24 | 17 |
| 2009 | 7 | 22 |
| 2010 | 18 | 29 |
| 2011 | 17 | 28 |
| 2012 | 14 | 37 |
| 2013 | 23 | 33 |
| 2014 | 18 | 25 |
| 2015 | 25 | 26 |
| 2016 | 20 | 56 |
| 2017 | 19 | 31 |
| 2018 | 20 | 41 |
| 2019 | 27 | 42 |
| 2020 | 34 | 50 |
| 2021 | 29 | 44 |
| 2022 | 27 | 55 |
| 2023 | 26 | 50 |
| 2024 | 21 | 52 |
| 2025 | 35 | 79 |
| 2026 | 18 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Histone deacetylase inhibitors for use in immunotherapy22 Sep 2026US 12,740,986 B2Viracta Subsidiary, Inc.
- Compositions and methods of treating age-related retinal dysfunction18 Aug 2026US 12,708,616 B2The Regents of the University of California
- Polyactive carbohydrates and methods of use thereof18 Aug 2026US 12,709,758 B2Bio Capital Holdings, LLC
- Methods and compositions for rejuvenating CNS glial populations by suppresion of transcription factors21 Jul 2026US 12,686,868 B2University of Rochester
- Recombinant lysin and its use in the treatment of Gram-negative bacterial infections16 Jun 2026US 12,655,409 B2Telum Therapeutics S.L.
- New high expression and high activity n-glycosidases, methods of production and applications thereof8 Oct 2026US 2026/0308562 A1Centre National de la Recherche Scientifique (CNRS)
- Hdac inhibitors for use with nk cell based therapies24 Sep 2026US 2026/0284060 A9NantKwest, Inc.
- Histone deacetylase inhibitors for use in immunotherapy24 Sep 2026US 2026/0284061 A9Viracta Subsidiary, Inc.
- Liquid enzyme preparation24 Sep 2026US 2026/0286333 A1Amano Enzyme Inc.
- Biosynthesis of beta-lactam antibiotics24 Sep 2026US 2026/0286334 A1
Most cited
By later US patents
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Histone deacetylases, and uses related thereto116US 6,777,217 B1President and Fellows of Harvard College · 2004
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996
- Recombination of polynucleotide sequences using random or defined primers91US 6,153,410 ACalifornia Institute of Technology · 2000
- CNS targeting AAV vectors and methods of use thereof91US 9,102,949 B2University of Massachusetts · 2015